Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis

Cited by (1,001)

Items 901–1,000 of 1,001

1. The Evolving View of Uremic Toxicity
   Björn K.I. Meijers, Jerome Lowenstein · 2022 · Toxins
2. Complicaciones microvasculares de la diabetes
   P. García-Ocaña, Lidia Cobos-Palacios, Luis Francisco Caballero Martínez · 2020 · Medicine - Programa de Formación Médica Continuada Acreditado
3. Health Needs Assessment: Chronic Kidney Disease Secondary to Type 2 Diabetes Mellitus in a Population without Social Security, Mexico 2016–2032
   Silvia Martínez Valverde, Rodrigo Zepeda‐Tello, Angélica Castro‐Ríos, Filiberto Toledano‐Toledano, Hortensia Reyes‐Morales, Adrián Rodriguez-Matías, Luis Gerardo Duran-Arenas · 2022 · International Journal of Environmental Research and Public Health
4. CVD risk in non-albuminuric chronic kidney disease in hypertensive, non-diabetic subjects: A post-hoc analysis from SPRINT
   Chang‐Sheng Sheng, Dan Wang, Jiangzi Yuan, Yi Cheng, Siming Sun, Yulin Yang, Ya Miao, Weiming Wang, Jingyan Tian, Zachary T. Bloomgarden · 2022 · Frontiers in Cardiovascular Medicine
5. Changes in urinary albumin as a surrogate for kidney disease progression in people with type 2 diabetes
   Yoichi Yokoyama, Ko Hanai, Tomomi Mori, Yui Yamamoto, Naoshi Yoshida, Hidekazu Murata, Tomohiro Shinozaki, Tetsuya Babazono · 2023 · Clinical and Experimental Nephrology
6. Diabetes Mellitus in Patients Undergoing Mitral Transcatheter Edge-to-Edge Repair—A Decade Experience in 1000+ Patients
   Michael Paukovitsch, Dominik Felbel, Matthias Groeger, Wolfgang Rottbauer, Sinisa Markovic, Marijana Vaso Tadic, Leonhard Moritz Schneider, Mirjam Keßler · 2023 · Journal of Clinical Medicine
7. Identifying cellular senescence associated genes involved in the progression of end-stage renal disease as new biomarkers
   Yujia Xi, Qiang Guo, Ran Zhang, Guo-sheng Duan, Sheng‐Xiao Zhang · 2023 · BMC Nephrology
8. The number of nephroprotection targets attained is associated with cardiorenal outcomes and mortality in patients with diabetic kidney disease. The CKD‐REIN cohort study
   Fabrice Bonnet, Beverley Balkau, Oriane Lambert, Yakhara Diawara, Christian Combe, Luc Frimat, Maurice Laville, Sophie Liabeuf, Ziad A. Massy, Marie Metzger et al. · 2024 · Diabetes Obesity and Metabolism
9. Comparative effects of sodium–glucose cotransporter 2 inhibitors versus dipeptidyl peptidase-4 inhibitors on kidney function decline in Japanese individuals with type 2 diabetes
   Naoshi Yoshida, Ko Hanai, Tetsuya Babazono · 2024 · Clinical and Experimental Nephrology
10. Chronic kidney disease progression in diabetic patients: Real world data in general practice
    Michelangelo Rottura, Selene Francesca Anna Drago, Viviana Maria Gianguzzo, Antonino Molonia, Giovanni Pallio, Riccardo Scoglio, Sebastiano Marino, Angela Alibrandi, Egidio Imbalzano, Francesco Squadrito et al. · 2024 · Heliyon
11. Prospective Study on Kidney Dysfunction Markers and Risk for Mortality among South Asians
    Ram Jagannathan, Shuchi Anand, Dimple Kondal, Jialin Han, Maria E. Montez‐Rath, Mohammed Kumail Ali, Shivani Anil Patel, Kavita Singh, Roopa Shivashankar, R.M. Anjana et al. · 2024 · Kidney International Reports
12. Plasma Biomarkers of Kidney Health and Mortality in Diabetes and Chronic Kidney Disease in the REGARDS Study
    Teresa K. Chen, Michelle M. Estrella, Ronit Katz, Mark J. Sarnak, Morgan Erika Grams, Mary Cushman, Emily B. Levitan, Chirag R. Parikh, Paul L. Kimmel, Joseph Vincent Bonventre et al. · 2024 · Clinical Journal of the American Society of Nephrology
13. Several Conventional Risk Markers Suggesting Presence of Albuminuria Are Weak Among Rural Africans With Hypertension
    Jon Rasmussen, Lovisa S. Nordin, Jakúp A. Thomsen, Peter R Rossing, Ib Christian Bygbjerg, Dirk L. Christensen · 2015 · Journal of Clinical Hypertension
14. Nephrology for the people: Presidential Address at the 42nd Regional Meeting of the Japanese Society of Nephrology in Okinawa 2012
    Kunitoshi Iseki · 2013 · Clinical and Experimental Nephrology
15. Comparison between Cystatin C- and Creatinine-Estimated Glomerular Filtration Rate in Cardiology Patients
    Axel Åkerblom, Johanna Helmersson‐Karlqvist, Mats Flodin, Anders Olof Larsson · 2015 · Cardiorenal Medicine
16. Association between renal function impairment and multivessel involvement in patients with acute ST-elevation myocardial infarction
    Rei-Yeuh Chang, Han‐Lin Tsai, Malcolm Koo, How‐Ran Guo · 2020 · Aging
17. Serum Klotho protein level in type 2 diabetic patients depending on the renal function
    И. И. Топчий, P. S. Semenovykh, T. D. Shcherban, V. Yu. Galchinska, K. O. Savicheva · 2020 · Ukrainian Journal of Nephrology and Dialysis
18. Renal function during hospitalization and outcome in Chinese patients with acute decompensated heart failure: A retrospective study and literature review
    Hao‐Wei Lee, Chin‐Chou Huang, Chih‐Yu Yang, Hsin‐Bang Leu, Po‐Hsun Huang, Tao-Cheng Wu, Shing‐Jong Lin, Jaw‐Wen Chen · 2022 · Clinical Cardiology
19. Whether Renal Pathology Is an Independent Predictor for End-Stage Renal Disease in Diabetic Kidney Disease Patients with Nephrotic Range Proteinuria: A Biopsy-Based Study
    Tingli Wang, Junlin Zhang, Yiting Wang, Lijun Zhao, Yucheng Wu, Honghong Ren, Yutong Zou, Rui Zhang, Huan Xu, Zhonglin Chai et al. · 2022 · Journal of Clinical Medicine
20. Efficacy of Lanthanum Carbonate and Sevelamer Carbonate as Phosphate Binders in Chronic Kidney Disease—A Comparative Clinical Study
    Parminder Nain, Narendra Nayak, Mary C. Maj, Rohit Singh, Jaspreet Kaur, Yujin Jeong, Sabyasachi Maity, Reetuparna Nath, Robert H. Hilgers, Shreya Nauhria et al. · 2023 · Pharmacy
21. International Variability of Renal and Cardiovascular Outcomes and Mortality in Patients with Type 2 Diabetes Mellitus in Europe
    Stefanie Thöni, Felix Keller, Sara Denicolò, Susanne Eder, Lukas Buchwinkler, László Rosivall, Andrzej Więcek, Patrick Barry Mark, Peter R Rossing, Hiddo J.L. Heerspink et al. · 2023 · Kidney & Blood Pressure Research
22. Association between the dietary inflammatory index and markers of endothelial and systemic inflammation in hemodialysis patients
    Arman Arab, Elham Karimi, Maryam Nazari, Hadi Tabibi, Atefeh As’habi · 2023 · Frontiers in Nutrition
23. ENFERMEDAD CARDIOVASCULAR (ECV) EN LA ENFERMEDAD RENAL CRÓNICA (ERC)
    Rodrigo Orozco B · 2015 · Revista Médica Clínica Las Condes
24. Renal effects of sacubitril/valsartan in patients with diabetes
    Stefan Störk · 2018 · The Lancet Diabetes & Endocrinology
25. Could occupational physical activity mitigate the link between moderate kidney dysfunction and coronary heart disease?
    Yolande Esquirol, Mark A. Tully, Jean‐Bernard Ruidavets, Damian G. Fogarty, Jean Ferrières, Michael P. Quinn, Maria Hughes, Frank Kee · 2014 · International Journal of Cardiology
26. Association of chronic kidney disease with adverse outcomes – Authors' reply
    Bakhtawar Khan Mahmoodi, Caroline S. Fox, Brad C. Astor, Robert G. Nelson, Kunihiro Matsushita, Josef Coresh · 2013 · The Lancet
27. Cardiovascular disease risk estimates for primary prevention in the US prediabetes and diabetes population using the PREVENT equation
    Xunliang Li, Wenman Zhao, Zhao Li, Tongxin Sun, Hai‐Feng Pan, Deguang Wang · 2025 · Diabetes Obesity and Metabolism
28. 2025 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline for the Primary Care Management of Chronic Kidney Disease
    Amy R. Schwartz, Jonathan A. Sosnov, Jonathan Brown, Cynthia Delgado, Linda F. Fried, Manjula Kurella Tamura, John W. Morrison, Sankar Dass Navaneethan, Paul M. Palevsky, Diane B. Rybacki et al. · 2025 · Annals of Internal Medicine
29. Prevalence of chronic kidney disease and associated risk factors in patients with Type 2 Diabetes Mellitus in Basrah, Iraq: A cross-sectional study
    Haider Ayad Alidrisi, Khulood Abed Reman, Emad Sakran Alhubaish, Ibrahim Hani Hussein, Hussein Ali Nwayyir, Ibrahim Abbood Zaboon, Musaab Ali Ashkar, Ali Hussain Ali Alhamza, Abbas Ali Mansour · 2026 · Diabetes Epidemiology and Management
30. Etiology of Persistent Microalbuminuria in Nigeria (P_MICRO study): protocol and study design
    C. William Wester, Bryan E. Shepherd, Usman J. Wudil, Baba Maiyaki Musa, Donna J. Ingles, Heather Leanne Prigmore, Faisal Saleh Dankishiya, Aima A. Ahonkhai, Bukar Alhaji Grema, Philip J. Budge et al. · 2022 · BMC Infectious Diseases
31. Prognostic impact of switching to the 2021 chronic kidney disease epidemiology collaboration creatinine-based equation in Caucasian patients with type 2 diabetes: the Renal Insufficiency and Cardiovascular events (RIACE) Italian Multicenter Study
    Monia Garofolo, Martina Vitale, Giuseppe Penno, Anna Solini, Emanuela Orsi, Valeria Grancini, Enzo Bonora, Cecilia Fondelli, Roberto Trevisan, Monica Vedovato et al. · 2024 · Cardiovascular Diabetology
32. Benefits of aldosterone receptor antagonism in chronic kidney disease: the BARACK-D RCT
    Richard F. Hobbs, Richard J. McManus, Clare J Taylor, Nicholas Robert Jones, Joy K Rahman, Jane L. Wolstenholme, Louise Jones, Jennifer A. Hirst, Sam Mort, Ly‐Mee Yu · 2025 · Health Technology Assessment
33. Mediating Effect of Established Risk Factors on Association Between Social Determinants and Cardiovascular Disease Mortality
    William J. He, Siyi Geng, Ling Tian, Frank B. Hu · 2025 · JACC Advances
34. Association of Left Atrium Remodeling With Major Adverse Cardiovascular Events in Asymptomatic Type 2 Diabetes Patients With Early Chronic Kidney Disease
    Mingxia Gong, Min Xu, Suoya Pan, Shu Jiang, Xiaohong Jiang · 2025 · Reviews in Cardiovascular Medicine
35. The Cornish experience of the ASSIST-CKD project
    Anna L. Barton, Angela S. Mallard, Anthea Patterson, Nicola Thomas, Stephen J. Dickinson, Hugh Gallagher · 2017 · Annals of Clinical Biochemistry International Journal of Laboratory Medicine
36. Insulin Resistance is Associated with Subclinical Vascular Injury in Patients with a Kidney Disease
    María M. Adeva-Andany, C. Fernández-Fernández, Lucía Adeva-Contreras, Natalia Carneiro-Freire, A. Domínguez-Montero, D. Mouriño-Bayolo · 2020 · Current Cardiology Reviews
37. Early diagnosis of chronic kidney disease in patients with diabetes in France: multidisciplinary expert opinion, prevention value and practical recommendations
    Thierry P. Hannedouche, Patrick Rossignol, Patrice Darmon, Jean‐Michel Halimi, Patrick Vuattoux, Albert Alain Hagège, Ludivine Videloup, Francis Guinard · 2023 · Postgraduate Medicine
38. Chronic kidney disease in America, Africa, and Asia: Overview of treatment cost and options
    Rania Mourchid, Amal Yassine, Mohammed Bellahcen, Yahia Cherrah, Samira Serragui · 2024 · Annales Pharmaceutiques Françaises
39. Renal function as an effect modifier of intensive glucose control in delaying cognitive function decline among individuals with type 2 diabetes: A revisit to the ACCORD MIND trial
    Piaopiao Li, Hamed Kianmehr, Dawei Guan, Ambar Kulshreshtha, K.M. Venkat Narayan, Mohammed Kumail Ali, Guillermo E. Umpierrez, Xin Hu, Vivian Andrew Fonseca, Lizheng Shi et al. · 2024 · Diabetes Obesity and Metabolism
40. Absence of progression risk of chronic kidney disease in patients with urine protein-creatinine ratio below 500 mg/g: a cohort study with competing risk analysis
    Jiang Bai, Lijuan Zhang, Jingkai Di, Wenyu Wang, Yawen Wu, Yun Zhou · 2025 · Frontiers in Medicine
41. Assessment of microalbuminuria in hypertensive patients with established coronary artery disease
    Delia Lidia Șalaru, Liviu Macovei, Cristian Stătescu, Cătălina Arsenescu Georgescu · 2013 · Revista română de medicină de laborator
42. Early Renal Abnormalities as an Indicator of Cardiovascular Risk in Type 2 Diabetes
    Francesca Chiara Viazzi, Barbara Bonino, Elena Ratto, Salvatore De Cosmo, Roberto Pontremoli · 2014 · High Blood Pressure & Cardiovascular Prevention
43. Changes in Urinary Biomarkers Over 10 Years Is Associated With Viral Suppression in a Prospective Cohort of Women Living With HIV
    Sanjiv M. Baxi, Rebecca Scherzer, Vasantha Jotwani, Michelle M. Estrella, Alison G. Abraham, Chirag R. Parikh, MICHAEL R. BENNETT, Mardge H. Cohen, Marek J. Nowicki, Deborah Gustafson et al. · 2016 · JAIDS Journal of Acquired Immune Deficiency Syndromes
44. Association of urinary albumin excretion with periodontal parameters in patients with type 2 diabetes mellitus: a cross-sectional study
    Michio Tanaka, Tatsuo Yamamoto, Nobuichi Kuribayashi, FUMINOBU OKUGUCHI, Haruhiko Isotani, Masahiro Iwamoto, Hidekatsu Sugimoto, Osamu Nakagawa, Daisuke Suzuki, Katsushige Abe et al. · 2019 · Diabetology International
45. Non-diabetic end-stage renal disease in Saudis associated with polymorphism of MYH9 gene but not UMOD gene
    Khalid Mohamed Adam, Ali Mahmoud Mohammed, Abubakr Ali Elamin MohamedAhmed · 2020 · Medicine
46. Circulating endothelin-1 levels are positively associated with chronic kidney disease in women but not in men: a longitudinal study in the Vara-Skövde cohort
    Margareta I. Hellgren, Per‐Anders Jansson, Hormoz Alayar, Ulf Lindblad, Bledar Daka · 2021 · BMC Nephrology
47. Outcome Analysis and Risk Factors for Perioperative Myocardial Ischemia After Elective Aortic Surgery
    Dmitriy I. Dovzhanskiy, Petra Jäckel, Moritz Sebastian Bischoff, Maani Hakimi, Ulf Hinz, Dittmar Böckler · 2021 · Annals of Vascular Surgery
48. Obesity 2021: Current Clinical Management of a Chronic, Serious Disease
    Kushner · 2021 · The Journal of Family Practice
49. End-stage renal disease: incidence and prediction by coronary heart disease, and educational level. Follow-up from diagnosis of childhood-onset type 1 diabetes throughout Norway 1973–2017
    Maryam Saeed, Lars C. Stene, Anna Varberg Reisæter, Trond Geir Jenssen, Grethe Seppola Tell, German Tapia, Geir Joner, Torild Skrivarhaug · 2022 · Annals of Epidemiology
50. Clinical Evaluation of Niacin in Hemodialysis Patients with Hyperphosphatemia as Adjuvant to Calcium Carbonate
    Rana Bahaa Mohammed, Mohammed Mahmood Mohammed, Sfaa Jameel Naeemah · 2020 · Al Mustansiriyah Journal of Pharmaceutical Sciences
51. Case-Fatality and Temporal Trends in Patients with Psoriasis and End-Stage Renal Disease
    Johannes Wild, Karsten Keller, Susanne Helena Karbach, Julia Weinmann‐Menke, Thomas F. Münzel, Lukas Hobohm · 2022 · Journal of Clinical Medicine
52. The prognostic value of pre-operative coronary evaluation in kidney transplanted patients
    Tali Steinmetz, Leor Perl, Benaya Rozen‐Zvi, Mohamad Atamna, Ran Kornowski, Arthur Shiyovich, Ashraf Hamdan, Eviatar Nesher, Ruth Rahamimov, Tuvia Ben Gal et al. · 2022 · Frontiers in Cardiovascular Medicine
53. A prediction model to assess the risk of egfr loss in patients with type 2 diabetes and preserved kidney function: The amd annals initiative
    Giuseppina Tiziana Russo, Annalisa Giandalia, Antonio Ceriello, Paolo Di Bartolo, Graziano Di Cianni, Paola Fioretto, Carlo Bruno Giorda, Valeria Manicardi, Roberto Pontremoli, Francesca Chiara Viazzi et al. · 2022 · Diabetes Research and Clinical Practice
54. Risk of Major Cardiovascular Disease after Exposure to Contrast Media: A Nationwide Population-Based Cohort Study on Dialysis Patients
    Shih‐Ting Huang, Tung‐Min Yu, Chia‐Hsin Chen, Yun-Chung Cheng, Ya‐Wen Chuang, Cheng-Hsu Cheng, Jia‐Sin Liu, Chih‐Cheng Hsu, Ming‐Ju Wu · 2023 · Metabolites
55. Albuminuria and cardiorenal risk
    Panagiotis I. Georgianos, Evangelia C. Dounousi, Vassilios Liakopoulos · 2023 · Current Opinion in Cardiology
56. Effect of multifactorial intensive treatment in patients with diabetic kidney disease: A meta‐analysis with trial sequential analysis
    Jianfang Shan, Zhengling Xu · 2023 · Diabetes Obesity and Metabolism
57. Finerenone cardiorenal effects and its placement in treatment of chronic kidney disease in patients with type 2 diabetes mellitus: A review
    В. В. Салухов, Минара Шамхаловна Шамхалова, Alla V. Duganova · 2023 · Terapevticheskii arkhiv
58. Has the time come to step up to “triple therapy” for the treatment of diabetic kidney disease?
    Dimitrios Patoulias, Djordje S. Popovic, Nikolaos Fragakis, Manfredi Rizzo · 2023 · Diabetes Research and Clinical Practice
59. Fasting GLP-1 Levels and Albuminuria Are Negatively Associated in Patients with Type 2 Diabetes Mellitus
    Cheol-Won Jang, Tae Yang Yu, Jin Woo Jeong, Se Eun Ha, Rajan Singh, Moon Young Lee, Seungil Ro · 2024 · Journal of Personalized Medicine
60. Chronic Kidney Disease—Part 1: Evaluation & Risk Assessment in CKD, Methods to Delay CKD Progression
    Dana Larsen, Laalasa Varanasi, Michelle M. Estrella · 2024 · Advances in Kidney Disease and Health
61. Comparison of Hypertension in Migrant and Local Patients with Atherosclerotic Diseases: A Cross-Sectional Study in Shanghai, China
    Xin Gong, Jianwei Shi, Jiaoling Huang, Wenya Yu, Xiaojie Bo, Kangjie Xu, Ning Chen, Qian Liu, Chen Chen, Zhaoxin Wang · 2020 · Annals of Global Health
62. Screening for Autoantibodies in Type 1 Diabetes: A Call to Action
    Петерс · 2021 · The Journal of Family Practice
63. A possible relationship between renal impairment and complications development in type 2 diabetes mellitus: a prospective, observational study in Italy
    Fabio Fabbian, Alfredo De Giorgi, Marcello Monesi, Marco Pala, Ruana Tiseo, Silvia Forcellini, Alda Storari, Roberto Graziani, Riccardo Volpi, Dimitri P. Mikhailidis et al. · 2015 · Journal of Diabetes and its Complications
64. Decade-long trends (1999–2009) in the characteristics, management, and hospital outcomes of patients hospitalized with acute myocardial infarction with prior diabetes and chronic kidney disease
    Robert Joel Goldberg, Mayra S. Tisminetzky, David D. McManus, A. Ein Dor, Ruben Miozzo, Jorge Yarzebski, Joel M. Gore · 2015 · International Journal of Nephrology and Renovascular Disease
65. The Impact of Creatinine Clearance Rate, Daily Urinary Albumin, and Their Joint Effect on Predicting Death in Diabetic Inpatients After Discharge
    I‐Te Lee, Wayne Huey‐Herng Sheu, Shih‐Yi Lin · 2016 · Medicine
66. Spatial distribution of kidney disease in the contaminated site of Taranto (Italy)
    Marta Benedetti, Marco De Santis, Valerio Manno, Sante Minerba, Antonella Mincuzzi, Angela Morabito, Nicola Panocchia, Maria Eleonora Soggiu, Annalisa Tanzarella, Tiziano Pastore et al. · 2017 · American Journal of Industrial Medicine
67. Prognostic Factors of Fatal and Nonfatal Cardiovascular Events in Patients With Type 2 Diabetes: The Role of Renal Function Biomarkers
    Stefanos K. Roumeliotis, Vassilios Liakopoulos, Athanasios K. Roumeliotis, Aikaterini C. Stamou, Stylianos A. Panagoutsos, Graziella D’Arrigo, Giovanni Luigi Tripepi · 2021 · Clinical Diabetes
68. Aliskiren in Type 2 Diabetes and Cardiorenal End Points
    Marc Alan Pfeffer, Barry Morton Brenner, John J.V. McMurray · 2013 · New England Journal of Medicine
69. Indirect Effects of the COVID-19 Pandemic on In-Hospital Outcomes among Internal Medicine Departments: A Double-Center Retrospective Study
    Maurizio Di Marco, Nicoletta Miano, Simona Marchisello, Giuseppe Coppolino, Giuseppe L’Episcopo, Sabrina Scilletta, Concetta Spichetti, Serena Torre, Roberto Scicali, Luca Zanoli et al. · 2023 · Journal of Clinical Medicine
70. Association between urinary albumin-to-creatinine ratio within the normal range and continuous glucose monitoring-derived metrics in children and adolescents with type 1 diabetes
    László Barkai, Olivér Rácz, György Eigner, Levente Kovács · 2025 · Diabetology & Metabolic Syndrome
71. Diabetic retinopathy and chronic kidney disease synergistically increase the risk of incident cardiovascular disease in type 2 diabetes: Insights from two cohort studies
    Yeon Soo Park, Kyu‐na Lee, Bo Kyung Koo, Soo Heon Kwak, Kyungdo Han, Min Kyong Moon · 2025 · Diabetes Research and Clinical Practice
72. Optimising Access to Care for Patients with Heart and Kidney Diseases: A World Heart Federation and International Society of Nephrology White Paper
    Jagat Narula, Javed Butler, Mogamat‐Yazied Chothia, Debasish Bannerjee, Faiçal Jarraya, Ifeoma Ulasi, Valérie A. Luyckx · 2025 · African Journal of Nephrology
73. Albuminuria in Type 2 Diabetes and Risk of Cardiorenal Outcomes
    Saaima Parveen, Morten Winther Malmborg, Anojhaan Arulmurugananthavadivel, Nicholas Carlson, Charlotte Andersson, Camilla Fuchs Andersen, Jesper Jensen, Deewa Zahir, Mariam Elmegaard, Talip E Eroglu et al. · 2025 · JACC Advances
74. Association of periodontitis with reduced kidney function and albuminuria in early chronic kidney disease: a population-based study
    Christian Schmidt‐Lauber, Merle Ebinghaus, Katrin Borof, Berit Lieske, Alexandre Klopp, Christina Thompson, Loujain Wees, Zambaka Dawood, Guido Heydecke, Thomas Beikler et al. · 2026 · International Journal of Oral Science
75. Interaction between the stage of chronic kidney disease and diabetes mellitus as factors associated with mortality in chronic kidney disease patients: An external cohort study
    Laura Elisa Villegas Sierra, Melisa Buriticá Agudelo, Carlos Enrique Yepes Delgado, Yanett Marcela Montoya Jaramillo, Fabian Alberto Jaimes · 2022 · Nefrología (English Edition)
76. Relationship between plasma leucine-rich α-2-glycoprotein 1 and urinary albumin excretion in patients with type 2 diabetes
    Jin Ook Chung, Seon‐Young Park, Dong Hyeok Cho, Dong Jin Chung, Min Young Chung · 2023 · Frontiers in Endocrinology
77. Prevalence, impact and management of hypertension-mediated organ damage in type 2 diabetes patients
    A.A. Romero Secin, Javier Díez‐Espino, Miguel Ángel Prieto-Díaz, Vicente Pallarés‐Carratalá, Alfonso Barquilla-García, Rafael Manuel Micó-Pérez, José Polo García, Sonsoles M. Velilla-Zancada, Vicente Martín, Antonio Segura‐Fragoso et al. · 2024 · Medicina de Familia SEMERGEN
78. Integrating preventive cardiology in primary care
    Badour Subhi Alaujan, Bander Ahmad Zamzami, Hind Amer Ababtain, Fatmah Malfi Altalouhi, ‏Munifah Hamdan Alshammari, Eman Smair Alenizi, Ghuzyel Fahad Aldossary, ‏Reem Sultan Alshaibani, ‏Salwa Rashed Alowaidan, Albandary Falah Alharbi et al. · 2021 · International Journal of Health Sciences
79. Predicting renal function using fundus photography: role of confounders
    Hyunwoong Park, Hae-Ri Kim, Ki Yup Nam, Bum Jun Kim, Tae-Seen Kang · 2025 · The Korean Journal of Internal Medicine
80. Identifying pathways to cardiovascular mortality by causal graphical models and mediation analysis among hypertensive patients: insights from a prospective study
    Simiao Tian, Zhen Li, Yanhong Bi, Xiaoyu Che, Ao Feng, Yiou Wang · 2025 · Journal of Translational Medicine
81. Albuminuria
    Hiddo J.L. Heerspink, Ton J. Rabelink, Dick de Zeeuw · 2014 · Elsevier eBooks
82. Association of kidney disease measures with poor outcomes
    Paul E. Stevens, Chris Farmer · 2012 · The Lancet
83. Role of Ambulatory Blood Pressure Monitoring in Hypertension and Diabetes
    Colleen Ann Flynn, George L. Bakris · 2013 · Current Hypertension Reports
84. Cardiorenal biomarkers: one step closer
    Xiaojun Chen, Amir Lerman, Lilach O. Lerman · 2017 · Journal of Laboratory and Precision Medicine
85. Development of a novel AlphaLISA ImmunoAssay for Big angiotensin‐25
    Sayaka Nagata, Akihiro Fukuda, Masao Kikuchi, Yuji Sato, Masanao Nagatomo, Junko Aburaya, Shouichi Fujimoto, Kazuo Kitamura · 2020 · Nephrology
86. Evaluating predictors of renal injury with sorafenib in hepatocellular carcinoma: A multi-ethnic cohort study
    Kelsey H. Natsuhara, Li Zhang, Christopher A. Carlos, Hala T. Borno · 2021 · Journal of Onco-Nephrology
87. Diabetes and the kidney
    Tahseen Ahmad Chowdhury, Omer Ali · 2021 · Clinical Medicine
88. Impact of Different Approaches to Kidney Transplant with and without Chronic Hemodialysis on Cardiac Function and Morphology: A Case–Control Study
    Marta Obremska, Dorota Kamińska, Magdalena Krawczyk, Magdalena Krajewska, Wojciech Kosmala · 2021 · Journal of Clinical Medicine
89. Texture analysis of native T1 images as a novel method for non-invasive assessment of heart failure with preserved ejection fraction in end-stage renal disease patients
    Tianyi Zhang, Dong‐Aolei An, Hang Zhou, Zhaohui Ni, Qin Wang, Binghua Chen, Renhua Lu, Jiaying Huang, Yin Zhou, Doo Hee Kim et al. · 2022 · European Radiology
90. Recommendations for Early and Comprehensive Management of Type 2 Diabetes and Its Related Cardio-Renal Complications
    Ali K. Abu‐Alfa, Paola Atallah, Sami T. Azar, Elissar Dagher, Akram Salim Echtay, Mireille Amm, Habib G. Hazkial, Roland Kassab, R. Medlej, Malek A. Mohamad · 2022 · Diabetes Therapy
91. Potential Efficacy of Proteasome Inhibitor, Delanzomib, for the Treatment of Renal Fibrosis
    Ayano Sawa-Aihara, Katsuji Hattori, Goshi Nagao, Yoshihisa Yamada, Tatsuhiro Ishida · 2023 · Biological and Pharmaceutical Bulletin
92. Relationship Between Cardiovascular Events and Serum Lipid and Plasma Fatty Acid Profile in Maintenance Hemodialysis Patients With Diabetic Mellitus
    Norio Nakamura, Hiroshi Osawa, Daiki Nagawa, Masamichi Nakata, IKUYO NARITA-KINJO, Takeshi Fujita, Reiichi Murakami, Michiko Shimada, Hirofumi Tomita, Chikako Tsutaya et al. · 2023 · In Vivo
93. Screening and Management of Coronary Artery Disease in Kidney Transplant Candidates
    Giuseppe Vadalà, Chiara Alaimo, Giancarlo Buccheri, Luca Di Fazio, Leandro Di Caccamo, Vincenzo Sucato, Manlio Cipriani, Alfredo Ruggero Galassi · 2023 · Diagnostics
94. Estimation of serum and salivary creatinine and urea levels in chronic kidney disease: A case–control study
    Devika S Pıllaı, Subhas Babu, Renita Castelino, Sajad Ahmad Buch · 2023 · Journal of Indian Academy of Oral Medicine and Radiology
95. Impact of proteinuria on long-term prognosis in patients with coronary artery disease
    Hiroshi Funakubo, Akihito Tanaka, Akihiro Tobe, Takeshige Kunieda, Yoshiaki Kubota, Naoki Yoshioka, Satoshi Otsuka, Nobutaka Kudo, Yoshinori Shirai, Kenji Furusawa et al. · 2023 · Journal of Cardiovascular Medicine
96. Association of abnormalities in electrocardiography and ultrasonic echocardiography with the occurrence of cardiovascular disease in patients with advanced chronic kidney disease
    Ken Hirabayashi, Hideki Fujii, Keiji Kono, Satoshi Yamatani, Mao Shimizu, Kentaro Watanabe, Kazuo Sakamoto, Shunsuke Goto, Shinichi Nishi · 2023 · Clinical and Experimental Nephrology
97. Changes in Cardiac Structure and Function of Recipients after Kidney Transplantation
    Süleyman Akkaya, Ümit Çakmak · 2024 · Journal of Clinical Medicine
98. Finerenone: Who should prescribe it for CKD? The physician associate’s perspective
    Becky M. Ness, Heidi Webb · 2024 · Journal of Nephrology
99. Complicaciones macrovasculares de la diabetes. Evaluación del riesgo cardiovascular y objetivos terapéuticos. Estrategias de prevención y tratamiento
    José Antonio Gimeno Orna · 2016 · Medicine - Programa de Formación Médica Continuada Acreditado
100. Prevalence and risk factors of diabetic kidney disease in north eastern Nigeria
     Ijuptil K. Chiroma, Sulaiman MM, BM Mubi, Akilahyel Auta Ndahi, Ahidiyu Anaryu Mamza, Mustapha Lawan, Umar Loskurima, Jummai Shettima, Abdullahi Oteikwu Amali, Ibrahim Ummate · 2021 · Annals of African Medical Research